Financial reports
10-K
2023 FY
Annual report
8 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
10-K
2022 FY
Annual report
10 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
7 Oct 22
NT 10-Q
Notice of late quarterly filing
15 Aug 22
10-Q
2022 Q1
Quarterly report
27 May 22
NT 10-Q
Notice of late quarterly filing
16 May 22
Current reports
8-K
Regulation FD Disclosure
18 Apr 24
8-K
Allarity Therapeutics Announces 1-for-20 Reverse Stock Split
5 Apr 24
8-K
Material Modifications to Rights of Security Holders
4 Apr 24
8-K
Regulation FD Disclosure
1 Apr 24
8-K
Regulation FD Disclosure
26 Mar 24
8-K
Entry into a Material Definitive Agreement
19 Mar 24
8-K
Entry into a Material Definitive Agreement
15 Mar 24
8-K
Allarity Therapeutics Reports Full Year 2023 Financial Results and Provides a Business Update
8 Mar 24
8-K
Departure of Directors or Certain Officers
4 Mar 24
8-K
Entry into a Material Definitive Agreement
1 Mar 24
Registration and prospectus
S-1/A
IPO registration (amended)
17 Apr 24
424B5
Prospectus supplement for primary offering
15 Apr 24
424B5
Prospectus supplement for primary offering
12 Apr 24
424B5
Prospectus supplement for primary offering
11 Apr 24
424B5
Prospectus supplement for primary offering
9 Apr 24
S-1/A
IPO registration (amended)
5 Apr 24
S-8
Registration of securities for employees
25 Mar 24
424B5
Prospectus supplement for primary offering
19 Mar 24
D
$1.40 mm in debt, sold $400.00 k, 1 investor
2 Feb 24
S-1/A
IPO registration (amended)
15 Dec 23
Proxies
DEF 14A
Definitive proxy
7 Mar 24
PRER14A
Preliminary revised proxy
23 Feb 24
PRE 14A
Preliminary proxy
26 Jan 24
DEFA14A
Additional proxy soliciting materials
20 Jun 23
DEF 14A
Definitive proxy
6 Jun 23
PRE 14A
Preliminary proxy
26 May 23
DEF 14A
Definitive proxy
6 Mar 23
PRE 14A
Preliminary proxy
24 Feb 23
DEFA14A
Additional proxy soliciting materials
24 Jan 23
DEF 14A
Definitive proxy
6 Dec 22
Other
EFFECT
Notice of effectiveness
30 Nov 23
CORRESP
Correspondence with SEC
27 Nov 23
UPLOAD
Letter from SEC
8 Nov 23
EFFECT
Notice of effectiveness
20 Oct 23
CORRESP
Correspondence with SEC
17 Oct 23
UPLOAD
Letter from SEC
13 Oct 23
EFFECT
Notice of effectiveness
6 Jul 23
CORRESP
Correspondence with SEC
30 Jun 23
CORRESP
Correspondence with SEC
30 Jun 23
UPLOAD
Letter from SEC
12 Jun 23
Ownership
SC 13G/A
3i, LP
12 Feb 24
3
Laura Benjamin
28 Aug 23
3
Joseph Walter Vazzano
2 Aug 23
SC 13G
INTRACOASTAL CAPITAL, LLC
14 Jul 23
SC 13G
INTRACOASTAL CAPITAL, LLC
28 Apr 23
SC 13G/A
Forsakringsaktiebolaget Avanza Pension
10 Mar 23
SC 13G
3i, LP
2 Mar 23
SC 13G/A
Forsakringsaktiebolaget Avanza Pension
26 Jan 23
SC 13G/A
Forsakringsaktiebolaget Avanza Pension
25 Jan 23
SC 13G/A
Forsakringsaktiebolaget Avanza Pension
24 Jan 23